However, the published evidence has largely centered on pathologists’ visual enumeration of CD163+ TAMs with limited capability to objectively capture prognostic value embedded in the spatial relationship between of CD163+ TAMs and cancer cells. The gene discussed is CD163; the disease is cancer.